Burning Rock Q1 Revenues Slide 18.9% to RMB107.9M, Gross Margin Dips to 72.3%
BNR•Burning Rock’s Q1 revenues fell 18.9% year-over-year to RMB107.9 million (US$15.6 million), driven by a 15.3% drop in central laboratory and 8.5% decline in in-hospital testing. Net loss widened to RMB17.5 million (US$2.5 million) while gross margin dipped to 72.3%.
1. Financial Results
Burning Rock reported Q1 revenues of RMB107.9 million (US$15.6 million), an 18.9% year-over-year decline. Gross profit fell 19.9% to RMB78.0 million with gross margin at 72.3%, and net loss widened to RMB17.5 million (US$2.5 million).
2. Segment Performance
Central laboratory revenue dropped 15.3% to RMB32.3 million (US$4.7 million) as testing volume decreased during the shift to in-hospital testing. In-hospital business revenue declined 8.5% to RMB52.8 million (US$7.6 million), while pharma R&D services revenue fell 38.6% to RMB22.8 million (US$3.3 million) due to lower milestone progress.
3. Expense Control and Cash Position
Operating expenses decreased 14.0% to RMB96.9 million (US$14.1 million) driven by cost controls in R&D, marketing, and administrative functions. The company held RMB448.7 million (US$65.1 million) in cash and equivalents at March 31, 2026, supporting its ongoing NGS investments.
